Z79.631 Long term (current) use of antimetabolite agent
Billable / valid for submission ICD10CM Release FY2026
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | current | Long term (current) use of antimetabolite agent | yes |
Related codes in Z79
- Z79 Long term (current) drug therapy
- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets
- Z79.01 Long term (current) use of anticoagulants
- Z79.02 Long term (current) use of antithrombotics/antiplatelets
- Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
- Z79.2 Long term (current) use of antibiotics
- Z79.3 Long term (current) use of hormonal contraceptives
- Z79.4 Long term (current) use of insulin
- Z79.5 Long term (current) use of steroids
- Z79.51 Long term (current) use of inhaled steroids
- Z79.52 Long term (current) use of systemic steroids
- Z79.6 Long term (current) use of immunomodulators and immunosuppressants
- Z79.60 Long term (current) use of unspecified immunomodulators and immunosuppressants
- Z79.61 Long term (current) use of immunomodulator
- Z79.62 Long term (current) use of immunosuppressant
- Z79.620 Long term (current) use of immunosuppressive biologic
- Z79.621 Long term (current) use of calcineurin inhibitor
- Z79.622 Long term (current) use of Janus kinase inhibitor
- Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
- Z79.624 Long term (current) use of inhibitors of nucleotide synthesis